Annual reports and work programmes

The European Medicines Agency (EMA) publishes a full work programme and annual report, to provide an overview of the work of the Agency together with the European medicines regulatory network.
Corporate Governance

EMA publishes its annual reports in May / June following the year in question.

We also publish information on the volume and outcome of centralised procedures for human and veterinary medicines. For further details, see Medicine evaluation figures.

Our work programmes - also called programming documents - reflect our priorities and main focus areas for the corresponding period, as well of those of the European medicines regulatory network. 

The work programmes describe objectives and planned activities. They cover:

  • Human medicines evaluation activities - split into pre-authorisation, initial evaluation, post-authorisation, pharmacovigilance and referrals
  • Veterinary medicines evaluation activities - with a similar structure to the human medicines
  • Horizontal activities - that enable and support the evaluation of human and veterinary medicines, including committee coordination, inspections, partner and stakeholder relationship management, and data management
  • Corporate governance and support activities - including finance, human resources and quality management

2024 annual report

EMA's 2024 annual report offers insights into key initiatives and priority areas that guided our work in 2024.

The report highlights the outcomes of the evaluation and monitoring of human and veterinary medicines. 

It features key figures and an interactive timeline with milestones from 2024. 

Its timeline enables readers to explore each topic in depth by accessing relevant documents, audio-visual materials and infographics.

The report is available in two formats:

  • Digital version: with a fresh layout and new interactive features
  • PDF version: downloadable, printable format with figures and statistics on EMA's regulatory procedures and activities
EMA's 2024 annual report

2025

European Medicines Agency mid-year report 2025 (January-June 2025)

Reference Number: EMA/283452/2025

English (EN) (1.45 Mo - PDF)

First published:
Voir

Final programming document 2025-27

Adopted Reference Number: EMA/30979/2025

English (EN) (2.59 Mo - PDF)

First published:
Voir

2024

EMA's annual report 2024 is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2023 plus visuals and audio-visual materials exploring topics in depth
  • PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

2024 annual report of the European Medicines Agency

English (EN) (27.37 Mo - PDF)

First published:
Voir

Annexes - 2024 annual report of the European Medicines Agency

English (EN) (1.76 Mo - PDF)

First published:
Voir

Annex 10 - 2024 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

English (EN) (156.14 Ko - XLSX)

First published:
Voir

Final programming document 2024-2026

Adopted Reference Number: EMA/426707/2023

English (EN) (1.99 Mo - PDF)

First published:
Voir

Annual activity report 2024

Reference Number: EMA/69085/2025

English (EN) (3.47 Mo - PDF)

First published:
Voir

European Medicines Agency mid-year report 2024 (January-June 2024)

Reference Number: EMA/298094/2024

English (EN) (1.66 Mo - PDF)

First published:
Voir

2023

EMA's annual report 2023 is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2023 plus visuals and audio-visual materials exploring topics in depth
  • PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

2023 annual report of the European Medicines Agency

English (EN) (5.48 Mo - PDF)

First published: Last updated:
Voir

Annexes - 2023 annual report of the European Medicines Agency

English (EN) (1.42 Mo - PDF)

First published:
Voir

Annex 10 - 2023 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

English (EN) (142.69 Ko - XLSX)

First published:
Voir

Final programming document 2023-2025

Reference Number: EMA/36710/2023

English (EN) (1.94 Mo - PDF)

First published:
Voir

Annual activity report 2023

English (EN) (3.63 Mo - PDF)

First published: Last updated:
Voir

European Medicines Agency mid-year report 2023 (January-June 2023)

Reference Number: EMA/343593/2023

English (EN) (1.26 Mo - PDF)

First published:
Voir

2022

EMA's annual report 2022 is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2022 plus visuals and audiovisual materials exploring topics in depth
  • PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

2022 annual report of the European Medicines Agency

Adopted

English (EN) (9.52 Mo - PDF)

First published:
Voir

Annexes - 2022 annual report of the European Medicines Agency

English (EN) (1.44 Mo - PDF)

First published:
Voir

Annex 10 - 2022 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

English (EN) (143.93 Ko - XLSX)

First published:
Voir

Final programming document 2022-2024

Reference Number: EMA/32271/2022

English (EN) (2.19 Mo - PDF)

First published: Last updated:
Voir

Annual activity report 2022

Reference Number: EMA/137754/2023

English (EN) (2.07 Mo - PDF)

First published: Last updated:
Voir

European Medicines Agency mid-year report 2022 (January-June 2022)

Reference Number: EMA/697686/2022

English (EN) (1.07 Mo - PDF)

First published: Last updated:
Voir

2021

EMA's annual report 2021 is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2021 plus visuals and audiovisual materials exploring topics in depth
  • PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2021 annual report of the European Medicines Agency

Adopted

English (EN) (10.95 Mo - PDF)

First published:
Voir

Annexes - 2021 annual report of the European Medicines Agency

English (EN) (1.68 Mo - PDF)

First published:
Voir

Annex 10 - 2021 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

English (EN) (143.78 Ko - XLSX)

First published:
Voir

Final programming document 2021-2023

Reference Number: EMA/53919/2021 Summary:

Final programming document 2021-2023

English (EN) (1.98 Mo - PDF)

First published: Last updated:
Voir

Annual activity report 2021

Reference Number: EMA/75685/2022

English (EN) (2.18 Mo - PDF)

First published:
Voir

European Medicines Agency mid-year report 2021 (January-June 2021)

Reference Number: EMA/352298/2021

English (EN) (1.1 Mo - PDF)

First published: Last updated:
Voir

2020

EMA's annual report 2020 is available in two formats:

  • Digital version: view online for an interactive timeline of EMA’s main activities in 2020 plus visuals exploring topics in depth
  • PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2020 annual report of the European Medicines Agency

English (EN) (7.46 Mo - PDF)

First published:
Voir

Annexes - 2020 annual report of the European Medicines Agency

English (EN) (1.28 Mo - PDF)

First published:
Voir

Annex 10 - 2020 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

English (EN) (144.86 Ko - XLSX)

First published:
Voir

Annual activity report 2020

Reference Number: EMA/81758/2021

English (EN) (2.34 Mo - PDF)

First published:
Voir

Final programming document 2020-2022

Adopted Reference Number: EMA/9529/2020

English (EN) (1.87 Mo - PDF)

First published:
Voir

European Medicines Agency mid-year report 2020 (January-June 2020)

Reference Number: EMA/386447/2020

English (EN) (1.84 Mo - PDF)

First published:
Voir

2019

EMA's annual report 2019 is available in two formats:

  • Digital version with an interactive timeline of EMA's main activities in 2019 and key figures for the year;
  • PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2019 annual report of the European Medicines Agency

English (EN) (6.45 Mo - PDF)

First published:
Voir

Annexes - 2019 annual report of the European Medicines Agency

English (EN) (1.23 Mo - PDF)

First published:
Voir

Annex 10 – 2019 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

English (EN) (146.56 Ko - XLSX)

First published:
Voir

Annual activity report 2019

Reference Number: EMA/33568/2020

English (EN) (1020.99 Ko - PDF)

First published:
Voir

European Medicines Agency mid-year report 2019 from the Executive Director

Adopted Reference Number: EMA/619659/2019

English (EN) (771.6 Ko - PDF)

First published:
Voir

Final programming document 2019-2021

Adopted Reference Number: EMA/912857/2019

English (EN) (1.17 Mo - PDF)

First published:
Voir

2018

2018 annual report of the European Medicines Agency

English (EN) (10.43 Mo - PDF)

First published: Last updated:
Voir

Annexes - 2018 annual report of the European Medicines Agency

English (EN) (1.24 Mo - PDF)

First published:
Voir

Annex 10 – 2018 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Reference Number: EMA/848994/2019 Corr.2

English (EN) (147.96 Ko - XLSX)

First published: Last updated:
Voir

Annual activity report 2018

Reference Number: EMA/112688/2019

English (EN) (1.06 Mo - PDF)

First published:
Voir

Multiannual work programme 2018-2020

Reference Number: EMA/73199/2018

English (EN) (2.03 Mo - PDF)

First published: Last updated:
Voir

Annual report 2018 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)

Reference Number: EMA/131220/2019

English (EN) (205.1 Ko - PDF)

First published:
Voir

2017

2017 annual report of the European Medicines Agency

English (EN) (5.21 Mo - PDF)

First published: Last updated:
Voir

Annexes - 2017 annual report of the European Medicines Agency

English (EN) (1.42 Mo - PDF)

First published: Last updated:
Voir

Annex 10 – 2017 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Reference Number: EMA/780996/2017

English (EN) (147.88 Ko - XLSX)

First published: Last updated:
Voir

Annual activity report 2017

Adopted Reference Number: EMA/26967/2018

English (EN) (2.7 Mo - PDF)

First published: Last updated:
Voir

Work programme of the European Medicines Agency 2017

Reference Number: EMA/583016/2016 Rev. 1

English (EN) (1.18 Mo - PDF)

First published: Last updated:
Voir

2016

2016 annual report of the European Medicines Agency

English (EN) (9.61 Mo - PDF)

First published: Last updated:
Voir

Annexes - 2016 annual report of the European Medicines Agency

English (EN) (1.53 Mo - PDF)

First published: Last updated:
Voir

Annex 10 – 2016 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Reference Number: EMA/4995/2017

English (EN) (146.25 Ko - XLSX)

First published: Last updated:
Voir

Annual activity report 2016

Adopted Reference Number: EMA/141860/2017 Summary:

European Medicines Agency annual activity report 2016

English (EN) (1.45 Mo - PDF)

First published: Last updated:
Voir

European Medicines Agency mid-year report 2016 from the Executive Director

English (EN) (759.59 Ko - PDF)

First published: Last updated:
Voir

Multiannual work programme to 2020

Reference Number: EMA/319713/2016

English (EN) (331.88 Ko - PDF)

First published: Last updated:
Voir

Work programme of the European Medicines Agency 2016

Reference Number: EMA/92499/2016 Rev.1 Summary:

European Medicines Agency work programme 2016

English (EN) (698.11 Ko - PDF)

First published: Last updated:
Voir

български (BG) (123.45 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

español (ES) (89.85 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

čeština (CS) (126.23 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

dansk (DA) (93.83 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

Deutsch (DE) (98.19 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

eesti keel (ET) (86.33 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

ελληνικά (EL) (130.28 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

français (FR) (91.61 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

hrvatski (HR) (115.35 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

italiano (IT) (88.18 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

latviešu valoda (LV) (114.93 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

lietuvių kalba (LT) (117.13 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

magyar (HU) (117.89 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

Malti (MT) (123.63 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

Nederlands (NL) (89.61 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

polski (PL) (119.2 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

português (PT) (90.54 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

română (RO) (118.35 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

slovenčina (SK) (116.87 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

slovenščina (SL) (111.94 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

Suomi (FI) (86.23 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

svenska (SV) (87.73 Ko - PDF)

First published: 07/03/2016 Last updated: 11/07/2016
Voir

Annual report 2016 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)

Reference Number: EMA/184994/2017

English (EN) (85.29 Ko - PDF)

First published: Last updated:
Voir

2015

Annual activity report 2015

Reference Number: EMA/140840/2016 Summary:

European Medicines Agency annual activity report 2015

English (EN) (1.24 Mo - PDF)

First published: Last updated:
Voir

2015 annual report of the European Medicines Agency

Reference Number: Corr

English (EN) (6.98 Mo - PDF)

First published: Last updated:
Voir

Annexes - 2015 annual report of the European Medicines Agency

English (EN) (1.38 Mo - PDF)

First published: Last updated:
Voir

Annex 10 - 2015 annual report of the European Medicines Agency - Positive and negative opinions; Withdrawn applications

Reference Number: EMA/156961/2016

English (EN) (119.1 Ko - XLSX)

First published: Last updated:
Voir

European Medicines Agency mid-year report 2015 from the Executive Director

Reference Number: EMA/506004/2015 Summary:

Prepared by the Deputy Executive Director of the European Medicines Agency (EMA) for presentation to the Agency's Management Board on 2 October 2015.

English (EN) (549.96 Ko - PDF)

First published: Last updated:
Voir

Work programme of the European Medicines Agency 2015

Adopted Reference Number: EMA/773839/2014 Rev. 1

English (EN) (702.63 Ko - PDF)

First published: Last updated:
Voir

български (BG) (132.37 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

español (ES) (104.18 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

čeština (CS) (130.75 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

dansk (DA) (99.55 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

Deutsch (DE) (107.59 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

eesti keel (ET) (100.59 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

ελληνικά (EL) (134.47 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

français (FR) (103.89 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

hrvatski (HR) (121.63 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

italiano (IT) (101.24 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

latviešu valoda (LV) (124.15 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

lietuvių kalba (LT) (126.15 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

magyar (HU) (127.57 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

Malti (MT) (134.9 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

Nederlands (NL) (104.23 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

polski (PL) (125.74 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

português (PT) (104.66 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

română (RO) (153.64 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

slovenčina (SK) (125.06 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

slovenščina (SL) (120.7 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

Suomi (FI) (100.89 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

svenska (SV) (102.43 Ko - PDF)

First published: 02/03/2015 Last updated: 26/08/2015
Voir

Annual reports for the period from 2012 to 2015 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)

Reference Number: EMA/302717/2015

English (EN) (230.37 Ko - PDF)

First published: Last updated:
Voir

2014

Annual report of the European Medicines Agency 2014

Summary:

Annual report of the European Medicines Agency 2014

English (EN) (2.74 Mo - PDF)

First published: Last updated:
Voir

Annexes to the annual report of the European Medicines Agency 2014

Summary:

Annexes to the annual report of the European Medicines Agency 2014

English (EN) (1.33 Mo - PDF)

First published: Last updated:
Voir

Annual activity report 2014

Reference Number: EMA/92858/2015

English (EN) (728.39 Ko - PDF)

First published: Last updated:
Voir

Work programme of the European Medicines Agency 2014

Adopted Reference Number: EMA/695772/2013 Summary:

This work programme reflects the European Medicines Agency's (EMA) objectives and activities for

2014 that are aimed at reaching longer-term strategic goals.

English (EN) (496.75 Ko - PDF)

First published: Last updated:
Voir

2013

Annual report of the European Medicines Agency 2013

English (EN) (6.51 Mo - PDF)

First published: Last updated:
Voir

Annexes to the annual report of the European Medicines Agency 2013

English (EN) (1.02 Mo - PDF)

First published: Last updated:
Voir

Work programme of the European Medicines Agency 2013

Adopted Reference Number: EMA/MB/945561/2011

English (EN) (604.79 Ko - PDF)

First published: Last updated:
Voir

български (BG) (130.11 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

español (ES) (123.54 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

čeština (CS) (124.95 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

dansk (DA) (123.07 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

Deutsch (DE) (125.84 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

eesti keel (ET) (128.43 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

ελληνικά (EL) (133.33 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

français (FR) (124.28 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

italiano (IT) (122.63 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

latviešu valoda (LV) (122.67 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

lietuvių kalba (LT) (128.28 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

magyar (HU) (124.4 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

Malti (MT) (130.23 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

Nederlands (NL) (123.23 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

polski (PL) (124.69 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

português (PT) (140.57 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

română (RO) (123.7 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

slovenščina (SL) (156.22 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

Suomi (FI) (120.33 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

svenska (SV) (127.01 Ko - PDF)

First published: 13/03/2013 Last updated: 13/03/2013
Voir

2012

Annual report of the European Medicines Agency 2012

Adopted

English (EN) (8.19 Mo - PDF)

First published: Last updated:
Voir

Annexes to the annual report of the European Medicines Agency 2012

Adopted

English (EN) (1.17 Mo - PDF)

First published: Last updated:
Voir

Work programme of the European Medicines Agency 2012

Adopted Reference Number: EMA/MB/554514/2011

English (EN) (588.81 Ko - PDF)

First published: Last updated:
Voir

български (BG) (147.11 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

español (ES) (131.01 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

čeština (CS) (130.83 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

dansk (DA) (130.52 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

Deutsch (DE) (132.2 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

eesti keel (ET) (126.33 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

ελληνικά (EL) (144.61 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

français (FR) (130.58 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

italiano (IT) (129.03 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

latviešu valoda (LV) (135.21 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

lietuvių kalba (LT) (129.83 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

magyar (HU) (130.5 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

Malti (MT) (137.89 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

Nederlands (NL) (133.11 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

polski (PL) (131.3 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

português (PT) (132.02 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

română (RO) (131.26 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

slovenčina (SK) (134.58 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

slovenščina (SL) (128.96 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

Suomi (FI) (126.78 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

svenska (SV) (127.97 Ko - PDF)

First published: 17/02/2012 Last updated: 17/02/2012
Voir

2011

Annual report of the European Medicines Agency 2011

Adopted

English (EN) (3.08 Mo - PDF)

First published: Last updated:
Voir

Annual report 2011 (Annexes)

Adopted Reference Number: EMA/363033/2012

English (EN) (1.22 Mo - PDF)

First published: Last updated:
Voir

Work programme of the European Medicines Agency 2011

Adopted Reference Number: EMA/MB/482208/2010

English (EN) (380.18 Ko - PDF)

First published: Last updated:
Voir

български (BG) (44.51 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

español (ES) (49.51 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

čeština (CS) (42.88 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

dansk (DA) (40.95 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

Deutsch (DE) (54.5 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

eesti keel (ET) (38.77 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

ελληνικά (EL) (56.17 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

français (FR) (43.83 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

italiano (IT) (48.52 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

latviešu valoda (LV) (57.56 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

lietuvių kalba (LT) (45.11 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

magyar (HU) (41.38 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

Malti (MT) (57.84 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

Nederlands (NL) (41.69 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

polski (PL) (44.24 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

português (PT) (51.96 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

română (RO) (52.07 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

slovenčina (SK) (53.07 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

slovenščina (SL) (38.91 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

Suomi (FI) (50.11 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

svenska (SV) (41.91 Ko - PDF)

First published: 11/02/2011 Last updated: 11/02/2011
Voir

2010

Summary of the annual report of the European Medicines Agency 2010

Adopted Reference Number: EMA/697914/2011

English (EN) (187.95 Ko - PDF)

First published: Last updated:
Voir

български (BG) (280.41 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

español (ES) (176.26 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

čeština (CS) (252.2 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

dansk (DA) (179.32 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

Deutsch (DE) (244.99 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

eesti keel (ET) (187.29 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

ελληνικά (EL) (287.05 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

français (FR) (180.21 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

italiano (IT) (180.06 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

latviešu valoda (LV) (254.65 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

lietuvių kalba (LT) (247.56 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

magyar (HU) (307.81 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

Malti (MT) (302.14 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

Nederlands (NL) (181.51 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

polski (PL) (262.61 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

português (PT) (243.58 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

română (RO) (308.29 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

slovenčina (SK) (305.34 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

slovenščina (SL) (235.8 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

Suomi (FI) (256.41 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

svenska (SV) (175.79 Ko - PDF)

First published: 13/09/2012 Last updated: 13/09/2012
Voir

Annual report of the European Medicines Agency 2010

Adopted Reference Number: EMA/306870/2011

English (EN) (989.85 Ko - PDF)

First published: Last updated:
Voir

Annual report 2010 (Annexes)

Adopted Reference Number: EMA/457721/2011

English (EN) (1.3 Mo - PDF)

First published: Last updated:
Voir

Work programme for the European Medicines Agency 2010

Adopted Reference Number: EMA/MB/203131/2009

English (EN) (578.3 Ko - PDF)

First published: Last updated:
Voir

български (BG) (83.49 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

español (ES) (41.35 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

čeština (CS) (82.02 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

dansk (DA) (40.06 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

Deutsch (DE) (24.14 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

eesti keel (ET) (39.03 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

ελληνικά (EL) (72.38 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

français (FR) (22.96 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

latviešu valoda (LV) (77.42 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

lietuvių kalba (LT) (99.02 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

magyar (HU) (73.67 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

Malti (MT) (59.53 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

Nederlands (NL) (41.16 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

polski (PL) (77.65 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

português (PT) (40.54 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

română (RO) (64.96 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

slovenčina (SK) (93.98 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

slovenščina (SL) (58.85 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

Suomi (FI) (40.07 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

svenska (SV) (40.53 Ko - PDF)

First published: 19/03/2010 Last updated: 19/03/2010
Voir

2009

Summary of the annual report of the European Medicines Agency 2009

Adopted Reference Number: EMA/499025/2010

English (EN) (992.11 Ko - PDF)

First published: Last updated:
Voir

български (BG) (262.84 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

español (ES) (217.61 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

čeština (CS) (1020.99 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

dansk (DA) (140.48 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

Deutsch (DE) (143.04 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

eesti keel (ET) (996.12 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

ελληνικά (EL) (281.55 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

français (FR) (992.48 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

italiano (IT) (205.13 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

latviešu valoda (LV) (228.23 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

lietuvių kalba (LT) (194.47 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

magyar (HU) (1012.69 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

Malti (MT) (191.28 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

Nederlands (NL) (142.46 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

polski (PL) (191.43 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

português (PT) (202.27 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

română (RO) (191.81 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

slovenčina (SK) (241.79 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

slovenščina (SL) (178.43 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

Suomi (FI) (1015.21 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

svenska (SV) (139.23 Ko - PDF)

First published: 04/10/2010 Last updated: 04/10/2010
Voir

Annual report of the European Medicines Agency 2009

Adopted Reference Number: EMA/MB/69923/2010

English (EN) (974.81 Ko - PDF)

First published: Last updated:
Voir

Annual report 2009 (Annexes)

Adopted

English (EN) (594.67 Ko - PDF)

First published: Last updated:
Voir

Work programme for the European Medicines Agency 2009

Adopted Reference Number: EMEA/87375/2009 Adopted

English (EN) (458.93 Ko - PDF)

First published: Last updated:
Voir

български (BG) (133.92 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

español (ES) (36.43 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

čeština (CS) (112.42 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

dansk (DA) (35.57 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

Deutsch (DE) (37.79 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

eesti keel (ET) (34.13 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

ελληνικά (EL) (125.2 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

français (FR) (37.31 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

italiano (IT) (36.24 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

latviešu valoda (LV) (115.17 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

lietuvių kalba (LT) (110.28 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

magyar (HU) (106.36 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

Malti (MT) (111.44 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

Nederlands (NL) (37.05 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

polski (PL) (111.86 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

português (PT) (36.95 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

română (RO) (85.72 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

slovenčina (SK) (107.67 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

slovenščina (SL) (78.2 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

Suomi (FI) (35.21 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

svenska (SV) (36.01 Ko - PDF)

First published: 26/02/2009 Last updated: 26/02/2009
Voir

2008

Summary of the European Medicines Agency’s annual report for 2008

Adopted Reference Number: EMEA/362115/2009

English (EN) (109.32 Ko - PDF)

First published: Last updated:
Voir

български (BG) (381.67 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

español (ES) (580.1 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

čeština (CS) (337.86 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

dansk (DA) (126.2 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

Deutsch (DE) (137.31 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

eesti keel (ET) (137.15 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

ελληνικά (EL) (408.35 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

français (FR) (130.46 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

italiano (IT) (124.64 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

latviešu valoda (LV) (364.49 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

lietuvių kalba (LT) (326.94 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

magyar (HU) (299.13 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

Malti (MT) (349.14 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

Nederlands (NL) (129.25 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

polski (PL) (342.21 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

português (PT) (132.57 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

română (RO) (330.15 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

slovenčina (SK) (284.72 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

slovenščina (SL) (288.1 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

Suomi (FI) (121.92 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

svenska (SV) (123.11 Ko - PDF)

First published: 03/07/2009 Last updated: 03/07/2009
Voir

Annual report of the European Medicines Agency 2008

Adopted Reference Number: EMEA/330566/2009

English (EN) (753.4 Ko - PDF)

First published: Last updated:
Voir

Work programme for the European Medicines Agency 2008

Adopted Reference Number: EMEA/MB/487174/2007 Adopted

English (EN) (521.24 Ko - PDF)

First published: Last updated:
Voir

Summary of the work programme for the European Medicines Agency 2008

Adopted Reference Number: EMEA/MB/556125/2007

English (EN) (241.18 Ko - PDF)

First published: Last updated:
Voir

български (BG) (765.02 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

español (ES) (370.82 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

čeština (CS) (370.82 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

dansk (DA) (438.18 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

Deutsch (DE) (460.26 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

eesti keel (ET) (380.37 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

ελληνικά (EL) (774.18 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

français (FR) (382.91 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

italiano (IT) (424.74 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

latviešu valoda (LV) (649.4 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

lietuvių kalba (LT) (615.35 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

magyar (HU) (611.24 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

Malti (MT) (692.5 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

Nederlands (NL) (389.81 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

polski (PL) (614.05 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

română (RO) (803.54 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

slovenčina (SK) (641.77 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

slovenščina (SL) (544.46 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

Suomi (FI) (418.32 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

svenska (SV) (408.15 Ko - PDF)

First published: 28/03/2008 Last updated: 28/03/2008
Voir

2007

Summary of the European Medicines Agency’s annual report for 2007

Adopted Reference Number: EMEA/197729/2008/EN/FINAL

English (EN) (262.14 Ko - PDF)

First published: Last updated:
Voir

български (BG) (577.12 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

español (ES) (187.94 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

čeština (CS) (436.98 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

dansk (DA) (202.3 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

Deutsch (DE) (218.93 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

eesti keel (ET) (224.77 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

ελληνικά (EL) (592.53 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

français (FR) (194.33 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

italiano (IT) (192.99 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

latviešu valoda (LV) (488.24 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

lietuvių kalba (LT) (482.29 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

magyar (HU) (422.96 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

Malti (MT) (445.95 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

Nederlands (NL) (211.18 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

polski (PL) (444.28 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

português (PT) (204.82 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

română (RO) (505.95 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

slovenčina (SK) (449.82 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

slovenščina (SL) (384.58 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

Suomi (FI) (200.82 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

svenska (SV) (231.88 Ko - PDF)

First published: 17/06/2008 Last updated: 17/06/2008
Voir

Annual report of the European Medicines Agency 2007

Adopted Reference Number: EMEA/MB/17464/2008

English (EN) (1.31 Mo - PDF)

First published: Last updated:
Voir

Summary of the work programme for the European Medicines Agency 2007

Adopted Reference Number: EMEA/MB/442095/2006

English (EN) (262.37 Ko - PDF)

First published: Last updated:
Voir

български (BG) (600.06 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

español (ES) (255.51 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

čeština (CS) (523.62 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

dansk (DA) (265.68 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

Deutsch (DE) (277.08 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

eesti keel (ET) (315.58 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

ελληνικά (EL) (636.61 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

français (FR) (262.81 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

italiano (IT) (255.21 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

latviešu valoda (LV) (574.28 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

lietuvių kalba (LT) (507.42 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

magyar (HU) (501.44 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

Malti (MT) (512.39 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

Nederlands (NL) (313.26 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

polski (PL) (522.14 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

português (PT) (357.27 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

română (RO) (510.83 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

slovenčina (SK) (513.21 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

slovenščina (SL) (450.07 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

Suomi (FI) (249.13 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

svenska (SV) (266.36 Ko - PDF)

First published: 30/01/2007 Last updated: 30/01/2007
Voir

Work programme for the European Medicines Agency 2007

Adopted Reference Number: EMEA/MB/428793/2006/EN/FINAL

English (EN) (670.49 Ko - PDF)

First published: Last updated:
Voir

2006

Summary of the European Medicines Agency’s annual report for 2006

Adopted Reference Number: EMEA/88802/2007/EN/FINAL

English (EN) (212.44 Ko - PDF)

First published: Last updated:
Voir

български (BG) (586.61 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

español (ES) (254.62 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

čeština (CS) (494.63 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

dansk (DA) (247 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

Deutsch (DE) (262.59 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

ελληνικά (EL) (577.44 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

français (FR) (255.68 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

italiano (IT) (256.56 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

latviešu valoda (LV) (518.04 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

lietuvių kalba (LT) (494.47 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

magyar (HU) (441.34 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

Malti (MT) (489.97 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

polski (PL) (502.27 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

română (RO) (481.96 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

slovenščina (SL) (425.94 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

Suomi (FI) (288.32 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

svenska (SV) (243.55 Ko - PDF)

First published: 08/03/2007 Last updated: 08/03/2007
Voir

Annual report of the European Medicines Agency 2006

Adopted Reference Number: EMEA/MB/24167/2007/EN/FINAL

English (EN) (1.18 Mo - PDF)

First published: Last updated:
Voir

Summary of the work programme for the European Medicines Agency 2006

Adopted Reference Number: EMEA/62913/2006

English (EN) (268.02 Ko - PDF)

First published: Last updated:
Voir

español (ES) (288.04 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

čeština (CS) (572.92 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

dansk (DA) (279.94 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

Deutsch (DE) (198.41 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

eesti keel (ET) (275.99 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

ελληνικά (EL) (691.2 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

français (FR) (278.7 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

italiano (IT) (284.92 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

latviešu valoda (LV) (596.22 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

lietuvių kalba (LT) (580.96 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

magyar (HU) (545.33 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

Malti (MT) (611.25 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

Nederlands (NL) (285.88 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

polski (PL) (598.38 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

português (PT) (290.99 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

slovenčina (SK) (560.25 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

slovenščina (SL) (470.32 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

Suomi (FI) (277.72 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

svenska (SV) (278.52 Ko - PDF)

First published: 09/03/2007 Last updated: 09/03/2007
Voir

Work programme for the European Medicines Agency 2006

Adopted Reference Number: EMEA/MB/374230/2005

English (EN) (1.12 Mo - PDF)

First published: Last updated:
Voir

2005

Summary of the annual report of the European Medicines Agency 2005

Adopted Reference Number: EMEA/81246/2006

English (EN) (223.38 Ko - PDF)

First published: Last updated:
Voir

español (ES) (180.38 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

čeština (CS) (513.17 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

dansk (DA) (179.05 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

Deutsch (DE) (187.76 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

eesti keel (ET) (167.55 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

ελληνικά (EL) (590.39 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

français (FR) (184.36 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

italiano (IT) (181.98 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

latviešu valoda (LV) (539.32 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

lietuvių kalba (LT) (507.88 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

magyar (HU) (488.99 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

Malti (MT) (563.01 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

Nederlands (NL) (188.55 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

polski (PL) (521.25 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

português (PT) (240.85 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

slovenčina (SK) (489.58 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

slovenščina (SL) (470.36 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

Suomi (FI) (180.37 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

svenska (SV) (180.83 Ko - PDF)

First published: 09/03/2006 Last updated: 09/03/2006
Voir

Annual report of the European Medicines Agency 2005

Adopted Reference Number: EMEA/MB/63019/2006

English (EN) (2.59 Mo - PDF)

First published: Last updated:
Voir

Work programme for the European Medicines Agency 2005

Adopted Reference Number: EMEA/MB/138351/2004/en/Final

English (EN) (820.9 Ko - PDF)

First published: Last updated:
Voir

español (ES) (699.73 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

čeština (CS) (983.35 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

dansk (DA) (661.54 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

Deutsch (DE) (726.24 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

eesti keel (ET) (634.13 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

ελληνικά (EL) (3.14 Mo - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

français (FR) (702.34 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

italiano (IT) (702.36 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

latviešu valoda (LV) (1.22 Mo - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

lietuvių kalba (LT) (1.06 Mo - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

magyar (HU) (833.38 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

Malti (MT) (1.01 Mo - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

Nederlands (NL) (709.78 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

polski (PL) (987.14 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

português (PT) (695.58 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

slovenčina (SK) (824.67 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

slovenščina (SL) (720.68 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

Suomi (FI) (648.71 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

svenska (SV) (669.42 Ko - PDF)

First published: 16/02/2005 Last updated: 16/02/2005
Voir

1995-2004

Annual report of the European Medicines Agency 2004

Adopted Reference Number: EMEA/61492/2005/EN/Final

English (EN) (2.7 Mo - PDF)

First published: Last updated:
Voir

español (ES) (709.76 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

čeština (CS) (1.03 Mo - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

dansk (DA) (634.39 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

eesti keel (ET) (630.28 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

ελληνικά (EL) (1.22 Mo - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

français (FR) (971.11 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

italiano (IT) (780.38 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

latviešu valoda (LV) (997.43 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

lietuvių kalba (LT) (986.3 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

Malti (MT) (971.89 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

Nederlands (NL) (777.4 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

polski (PL) (1.05 Mo - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

português (PT) (661.84 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

slovenčina (SK) (992.91 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

slovenščina (SL) (1016.45 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

Suomi (FI) (645.32 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

svenska (SV) (647.35 Ko - PDF)

First published: 10/03/2005 Last updated: 10/03/2005
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 2004

Adopted Reference Number: EMEA/MB/58/03/en/FINAL

English (EN) (777.93 Ko - PDF)

First published: Last updated:
Voir

español (ES) (953.19 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

dansk (DA) (934.51 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

Deutsch (DE) (970.34 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

ελληνικά (EL) (1.32 Mo - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

français (FR) (995.36 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

italiano (IT) (966.44 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

Nederlands (NL) (968.13 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

português (PT) (1 Mo - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

Suomi (FI) (955.71 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

svenska (SV) (930.23 Ko - PDF)

First published: 06/02/2004 Last updated: 06/02/2004
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 2003

Adopted

English (EN) (809.94 Ko - PDF)

First published: Last updated:
Voir

español (ES) (1.1 Mo - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

dansk (DA) (941.54 Ko - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

Deutsch (DE) (980.4 Ko - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

ελληνικά (EL) (1.4 Mo - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

français (FR) (1.17 Mo - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

italiano (IT) (957.49 Ko - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

Nederlands (NL) (965.63 Ko - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

português (PT) (981.76 Ko - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

Suomi (FI) (950.65 Ko - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

svenska (SV) (967.49 Ko - PDF)

First published: 11/03/2004 Last updated: 11/03/2004
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 2003

Adopted

English (EN) (497.41 Ko - PDF)

First published: Last updated:
Voir

español (ES) (538.28 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

dansk (DA) (533.44 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

Deutsch (DE) (555.08 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

ελληνικά (EL) (819.71 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

français (FR) (586.6 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

italiano (IT) (546.3 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

Nederlands (NL) (539.71 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

português (PT) (572.77 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

Suomi (FI) (532.97 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

svenska (SV) (521.03 Ko - PDF)

First published: 12/06/2003 Last updated: 12/06/2003
Voir

Annual report of the European Agency for the Evaluation of Medicinal Products 2002

Adopted

English (EN) (768.04 Ko - PDF)

First published: Last updated:
Voir

español (ES) (757.71 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

dansk (DA) (752.15 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

Deutsch (DE) (778.74 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

ελληνικά (EL) (1.14 Mo - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

français (FR) (769.12 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

italiano (IT) (763.87 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

Nederlands (NL) (766.68 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

português (PT) (733.38 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

Suomi (FI) (759.5 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

svenska (SV) (735.39 Ko - PDF)

First published: 19/12/2002 Last updated: 19/12/2002
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 2002

Adopted Reference Number: EMEA/MB/049/01-EN-Final

English (EN) (399.98 Ko - PDF)

First published: Last updated:
Voir

español (ES) (478.53 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

dansk (DA) (476.02 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

Deutsch (DE) (501.38 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

ελληνικά (EL) (766.43 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

français (FR) (478.02 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

italiano (IT) (478.74 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

Nederlands (NL) (478.35 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

português (PT) (498.45 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

Suomi (FI) (467.35 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

svenska (SV) (477.28 Ko - PDF)

First published: 02/04/2002 Last updated: 02/04/2002
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 2001

Adopted

English (EN) (764.17 Ko - PDF)

First published: Last updated:
Voir

español (ES) (677.68 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

dansk (DA) (764.31 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

Deutsch (DE) (748.65 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

ελληνικά (EL) (1009.29 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

français (FR) (761.58 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

italiano (IT) (763.49 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

Nederlands (NL) (774.79 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

português (PT) (772.89 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

Suomi (FI) (760.36 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

svenska (SV) (671.05 Ko - PDF)

First published: 18/12/2001 Last updated: 18/12/2001
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 2001-2002

Adopted

English (EN) (1.3 Mo - PDF)

First published: Last updated:
Voir

español (ES) (636.71 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

dansk (DA) (617.72 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

Deutsch (DE) (636.96 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

ελληνικά (EL) (2.1 Mo - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

français (FR) (552.42 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

italiano (IT) (632.58 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

Nederlands (NL) (630.57 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

português (PT) (543.26 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

Suomi (FI) (605.6 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

svenska (SV) (615.64 Ko - PDF)

First published: 05/06/2001 Last updated: 05/06/2001
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 2000

Adopted

English (EN) (930.63 Ko - PDF)

First published: Last updated:
Voir

español (ES) (467.37 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

dansk (DA) (554.39 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

Deutsch (DE) (465.89 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

ελληνικά (EL) (2.82 Mo - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

français (FR) (459.58 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

italiano (IT) (662.65 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

Nederlands (NL) (624.03 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

português (PT) (631.38 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

Suomi (FI) (600.28 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

svenska (SV) (612.81 Ko - PDF)

First published: 20/12/2000 Last updated: 20/12/2000
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 2000-2001

Adopted

English (EN) (456.36 Ko - PDF)

First published: Last updated:
Voir

español (ES) (463.85 Ko - PDF)

First published: 16/02/2001 Last updated: 16/02/2001
Voir

Deutsch (DE) (465.92 Ko - PDF)

First published: 16/02/2001 Last updated: 16/02/2001
Voir

français (FR) (462.29 Ko - PDF)

First published: 16/02/2001 Last updated: 16/02/2001
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 1999

Adopted

English (EN) (536.39 Ko - PDF)

First published: Last updated:
Voir

español (ES) (433.06 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

dansk (DA) (438.23 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

Deutsch (DE) (437.75 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

ελληνικά (EL) (894.73 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

français (FR) (433.37 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

italiano (IT) (459.09 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

Nederlands (NL) (509.01 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

português (PT) (680.14 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

Suomi (FI) (433.5 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

svenska (SV) (337.29 Ko - PDF)

First published: 01/12/1999 Last updated: 01/12/1999
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 1999-2000

Adopted

English (EN) (1.92 Mo - PDF)

First published: Last updated:
Voir

español (ES) (772.43 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

dansk (DA) (219.6 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

Deutsch (DE) (793.13 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

français (FR) (784.66 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

italiano (IT) (245.38 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

Nederlands (NL) (179.55 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

português (PT) (196.5 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

Suomi (FI) (211.59 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

svenska (SV) (172.97 Ko - PDF)

First published: 02/06/1999 Last updated: 02/06/1999
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 1998

Adopted

English (EN) (549.46 Ko - PDF)

First published: Last updated:
Voir

español (ES) (732.26 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

dansk (DA) (342.36 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

Deutsch (DE) (796.66 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

ελληνικά (EL) (774.02 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

français (FR) (750.64 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

italiano (IT) (358.99 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

Nederlands (NL) (361.36 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

português (PT) (290.97 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

Suomi (FI) (359.26 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

svenska (SV) (347.93 Ko - PDF)

First published: 02/12/1998 Last updated: 02/12/1998
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 1998-1999

Adopted

English (EN) (729.61 Ko - PDF)

First published: Last updated:
Voir

español (ES) (885.32 Ko - PDF)

First published: 13/10/1998 Last updated: 13/10/1998
Voir

Deutsch (DE) (719.1 Ko - PDF)

First published: 13/10/1998 Last updated: 13/10/1998
Voir

français (FR) (862.08 Ko - PDF)

First published: 13/10/1998 Last updated: 13/10/1998
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 1997

Adopted

English (EN) (390.97 Ko - PDF)

First published: Last updated:
Voir

español (ES) (519.24 Ko - PDF)

First published: 03/12/1997 Last updated: 03/12/1997
Voir

Deutsch (DE) (578.52 Ko - PDF)

First published: 03/12/1997 Last updated: 03/12/1997
Voir

français (FR) (422.48 Ko - PDF)

First published: 03/12/1997 Last updated: 03/12/1997
Voir

Work programme for the European Agency for the Evaluation of Medicinal Products 1997-1998

Adopted Reference Number: EMEA/MB/002/97.final

English (EN) (201.63 Ko - PDF)

First published: Last updated:
Voir

español (ES) (100.4 Ko - PDF)

First published: 11/02/1997 Last updated: 11/02/1997
Voir

Deutsch (DE) (109.41 Ko - PDF)

First published: 11/02/1997 Last updated: 11/02/1997
Voir

français (FR) (105.69 Ko - PDF)

First published: 11/02/1997 Last updated: 11/02/1997
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 1996

Adopted

English (EN) (687.38 Ko - PDF)

First published: Last updated:
Voir

español (ES) (650.99 Ko - PDF)

First published: 04/12/1996 Last updated: 04/12/1996
Voir

Deutsch (DE) (666.52 Ko - PDF)

First published: 04/12/1996 Last updated: 04/12/1996
Voir

français (FR) (656.62 Ko - PDF)

First published: 04/12/1996 Last updated: 04/12/1996
Voir

Annual report of the European Agency for Evaluation of Medicinal Products 1995

Adopted

English (EN) (154.56 Ko - PDF)

First published: Last updated:
Voir

Share this page

Back to top